explore -WSS

explore

author：explore 2025-09-28 23:11:38 - browse：85311

Astrazeneca office building -- health policy coverage from STAT — AstraZeneca is suing the Biden administration to stop a new Medicare drug price negotiation program. Adobe

WASHINGTON — AstraZeneca is the sixth drugmaker to pile on a legal challenge to the Biden administration’s drug pricing reform law.

The Medicare drug price negotiation program created in the Inflation Reduction Act is set to kick off in the next week, as officials will release the names of the first 10 medicines that will be selected for the program. Medicines are eligible for selection if they are one of the highest-spend drugs for Medicare, and they have no generic competition.

AstraZeneca makes drugs that could be selected for the list, and asked a Delaware district court judge to rule that Medicare acted illegally and that the law is unconstitutional.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： iTeos Therapeutics debuts first data on TIGIT

focus

WSS

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Zyn nicotine pouches become unlikely player in latest culture war

The Affordable Care Act has saved billions in health care costs

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Biogen walks away from Aduhelm, years after polarizing approval

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

leisure time

explore

explore

Affirmative action in medical school literally saved lives

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Wildfire smoke exposes gaps in outdoor worker protections

Startling documents reveal new facets of Sacklers' opioid empire

In Memoriam: Notable people who died in 2023

Investment in vaccine development is lagging, report finds

Drug repurposing or repositioning? The language matters

Childbirth

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

explore

Startling documents reveal new facets of Sacklers' opioid empire

Medicare Advantage insurers face 0.2% cut to 2025 payments

Heat waves linked to early deliveries, preterm births in new study

Syphilis numbers in the United States reach record heights

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Wegovy leads to weight loss. Can it treat depression, too?

focus

focus

explore

hotspot